phase iib elad trial of liraglutide in mild-moderate alzheimer’s disease
Published 2 years ago • 474 plays • Length 4:36Download video MP4
Download video MP3
Similar videos
-
3:14
evaluating the effect of diabetes drug liraglutide for alzheimer’s disease
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
0:49
time saved in alzheimer’s disease in phase iii trial of donanemab
-
1:34
new alzheimer disease clinical trial: semaglutide for alzheimer disease
-
0:46
uncovering the reality of end-stage alzheimer's: how the dying process unfolds 😶🌫
-
1:38
the potential of lecanemab for the treatment of early alzheimer’s disease
-
3:31
alz-801 phase ii data & launch of phase iii study in early alzheimer’s disease
-
2:02
lecanemab for the treatment of early alzheimer’s disease: the story so far
-
3:06
a review of current clinical trials in dementia with lewy bodies
-
4:59
lecanemab: phase ii open-label extension results
-
0:21
walking changes in dementia #shorts
-
1:36
long-term clinical results of tps in alzheimer’s disease
-
1:09:58
what’s new in alzheimer’s disease clinical trials?
-
1:31
phase ii study of lecanemab in early ad
-
3:36
alzheimer's disease: the power of faith, the science of hope
-
2:00
2-minute neuroscience: frontotemporal dementia (ftd)
-
59:38
clinical trials, fad variants, and the etiology of alzheimer’s disease
-
2:55
alzheimer’s drug trial results hailed as ‘revolutionary
-
9:17
clinical trial results | early alzheimer's can be reversed | dr dale bredesen